CHEWABLE TRAVEL TABLET BONINE ® FOR KIDS

Manufacturer: Insight Pharmaceuticals
Effective date: 2009-06-17
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:22:32

Label at a glance#

ProductBonine Kids

Active ingredientChlorcyclizine Hydrochloride

Label structure11 sections

Indications and uses

prevents and treats nausea, vomiting or dizziness associated with motion sickness

Dosage and administration

children 6 years of age and older: chew 1 tablet thoroughly every 6 to 8 hours do not exceed 3 tablets in 24 hours or as directed by a doctor dosage should be taken up to one hour before travel starts or at onset of symptoms

Storage and handling

store at room temperature 20°–25°C (86°–77°F)

Contacts and useful links#

PhoneLabel contact1-800-344-7239

Websitewww.insightpharma.com

www.insightpharma.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

ATTENTION: USE ONLY IF TABLET BLISTER SEALS ARE UNBROKEN.

OTC - QUESTIONS SECTION

Questions? Call 1-800-344-7239
www.insightpharma.com

SPL UNCLASSIFIED SECTION

Distr. by: INSIGHT Pharmaceuticals Corp.
Langhorne, PA 19047-1749

*DRAMAMINE is a registered trademark of McNEIL-PPC, Inc.

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)	Purpose
Cyclizine HCl 25 mg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Antiemetic

Uses

INDICATIONS & USAGE SECTION

prevents and treats nausea, vomiting or dizziness associated with motion sickness

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use in children under 6 years of age unless directed by a doctor

OTC - ASK DOCTOR SECTION

Do not take or give to children if they have a breathing problem such as chronic bronchitis or glaucoma without first consulting a doctor

Do not take or give to children if they are taking sedatives or tranquilizers without first consulting a doctor

OTC - WHEN USING SECTION

When using this product

do not exceed recommended dosage
drowsiness may occur
alcohol, sedatives, and tranquilizers may increase drowsiness
be careful when driving a motor vehicle or operating machinery

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

children 6 years of age and older: chew 1 tablet thoroughly every 6 to 8 hours
do not exceed 3 tablets in 24 hours or as directed by a doctor
dosage should be taken up to one hour before travel starts or at onset of symptoms

Other information

STORAGE AND HANDLING SECTION

store at room temperature 20°–25°C (86°–77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Croscarmellose Sodium, Ethylcellulose, D&C Red #27 Lake, FD&C Blue #2 Lake, Hydroxypropylcellulose, Hypromellose, Magnesium Stearate, Mannitol, N&A Flavors, Sorbitol, Sucralose

PRINCIPAL DISPLAY PANEL - Box of 8 Tablets

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CHEWABLE TRAVEL TABLET
BONINE_®

CYCLIZINE HYDROCHLORIDE • ANTIEMETIC

FOR KIDS
The Product to Use at the Onset of Symptoms

Berry Blast

8 Chewable Tablets

PRINCIPAL DISPLAY PANEL - Box of 8 Tablets

PRINCIPAL DISPLAY PANEL - Box of 12 Tablets

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BONUS 50% MORE
12 TABLETS FOR THE PRICE OF 8 TABLETS

CHEWABLE TRAVEL TABLET
BONINE_®

CYCLIZINE HYDROCHLORIDE • ANTIEMETIC

FOR KIDS
The Product to Use at the Onset of Symptoms

Berry Blast

12 Chewable Tablets

PRINCIPAL DISPLAY PANEL - Box of 12 Tablets

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1251331	Bonine For Kids 25 MG Chewable Tablet	PSN	1
1251329	cyclizine HCl 25 MG Chewable Tablet	PSN	1
1251331	cyclizine hydrochloride 25 MG Chewable Tablet [Bonine For Kids]	SBD	1
1251329	cyclizine hydrochloride 25 MG Chewable Tablet	SCD	1
1251331	Bonine For Kids 25 MG Chewable Tablet	SY	1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63736-044-08	2019-10-21	C162847	48780-1	956f9ecf-bdb1-621f-e053-dbdaa90a74ad	CHEWABLE TRAVEL TABLET BONINE ® FOR KIDS
63736-044-12	2019-10-21	C162847	48780-1	956f9ecf-bdb1-621f-e053-dbdaa90a74ad	CHEWABLE TRAVEL TABLET BONINE ® FOR KIDS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63736-044-08	BonineKids	8 in 1 BOX	TABLET, CHEWABLE	8		1
63736-044-12	BonineKids	12 in 1 BOX	TABLET, CHEWABLE	12		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63736-044	BONINE KIDS (CHLORCYCLIZINE HYDROCHLORIDE) TABLET, CHEWABLE [INSIGHT PHARMACEUTICALS]	1	Legacy NDC, 2 package rows	20090619_9220360a-67d3-4a14-ba21-304a06697cd4.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Chlorcyclizine Hydrochloride	ACTIVE INGREDIENT	NPB7A7874U	1
Chlorcyclizine	ACTIVE MOIETY	M26C4IP44P	1
Aluminum Oxide	INACTIVE INGREDIENT	LMI26O6933	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	1
FD&C Red No. 40	INACTIVE INGREDIENT	WZB9127XOA	1
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	1
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	1
Saccharin Sodium	INACTIVE INGREDIENT	SB8ZUX40TY	1
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
Stearic Acid	INACTIVE INGREDIENT	4ELV7Z65AP	1
vanilla	INACTIVE INGREDIENT	Q74T35078H	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Bonine Kids
Chlorcyclizine Hydrochloride
Chlorcyclizine
Crospovidone
FD&C Red No. 40
Aluminum Oxide
Lactose
Magnesium Stearate
Silicon Dioxide
Saccharin Sodium
Stearic Acid
vanilla

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
63736-044	63736-044-08, 63736-044-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Chlorcyclizine Hydrochloride	NPB7A7874U	ACTIM
Crospovidone	68401960MK	IACT
FD&C Red No. 40	WZB9127XOA	IACT
Aluminum Oxide	LMI26O6933	IACT
Lactose	J2B2A4N98G	IACT
Magnesium Stearate	70097M6I30	IACT
Silicon Dioxide	ETJ7Z6XBU4	IACT
Saccharin Sodium	SB8ZUX40TY	IACT
Stearic Acid	4ELV7Z65AP	IACT
vanilla	Q74T35078H	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 214 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	TABLET, CHEWABLE / ORAL		180 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	SUSPENSION / ORAL		64 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	POWDER / ORAL		25 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, CHEWABLE / ORAL	40 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	TABLET, FILM COATED / ORAL		176 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	TABLET, ORALLY DISINTEGRATING / ORAL		10 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED / ORAL		96 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, EXTENDED RELEASE / ORAL	2.22 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
Stearic Acid	STEARIC ACID	4ELV7Z65AP	SOLUTION / TOPICAL	NA		Exact identifier — unii candidate 26 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	TABLET / BUCCAL	0.4 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, FILM COATED / ORAL	2.5 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	TABLET / RECTAL	0.6 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FOR SUSPENSION / ORAL		220 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	SUSPENSION / ORAL	5000 mg/5ml		Exact identifier — unii candidate 34 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	WAFER / ORAL	8 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, DELAYED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	FILM / BUCCAL		3 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TAMPON / VAGINAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SUSPENSION, EXTENDED RELEASE / ORAL		70 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Magnesium Stearate	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Saccharin Sodium	SACCHARIN SODIUM	SB8ZUX40TY	GEL / DENTAL	0.3 %w/w		Exact identifier — unii candidate 34 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
Silicon Dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
Aluminum Oxide	ALUMINUM OXIDE	LMI26O6933	TABLET / ORAL	NA		Exact identifier — unii candidate 2 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
f119f7a7-c1a8-44a6-a678-0e13c46294fd			9220360a-67d3-4a14-ba21-304a06697cd4	2009-06-17	Warnings	Exact identifier spl id: f119f7a7-c1a8-44a6-a678-0e13c46294fd spl set id: 9220360a-67d3-4a14-ba21-304a06697cd4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.